B

BeOne

Global oncology therapeutics discovery, development, manufacturing

Senior Director – Global Hematology HEOR/RWE Lead - Global Health Economic & Outcomes Research / Real World Evidence, Hematology

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeRemote in USA$222k - $292k /yr

About the Job

Requirements

  • An advanced degree in Health Economics Outcomes Research (HEOR), Epidemiology, Public Health, Biostatistics, or a related discipline is required.
  • A PhD with 6 or more years, or a Master’s degree with 8 or more years, of related experience in the biopharmaceutical industry or consulting is required.
  • Demonstrated experience serving as an HEOR/RWE lead supporting product launch and lifecycle management is required.
  • Proven success leading and executing evidence generation strategy and HEOR deliverables is required.
  • Strong understanding of global market dynamics and reimbursement landscape, with experience supporting HTA and/or JCA submissions, is required.
  • Demonstrated research expertise designing and conducting HEOR/RWE studies, including indirect comparison, economic models, and comparative effectiveness studies, with success in data dissemination and communication, is required.
  • Applied AI understanding to enhance evidence generation and HEOR insights is required.
  • Ability to prioritize and manage multiple projects and meet objectives, timelines, and budgets is required.
  • Ability to work in a cross-functional matrix team environment and communicate and collaborate HEOR/RWE strategies and activities with internal and external stakeholders is required.
  • Proficiency in Microsoft Office and familiarity with statistical software, HEOR modeling tools, and AI-enabled approaches for evidence generation and communication are required.

Responsibilities

  • Lead and drive global HEOR/RWE strategy and evidence generation activities for BRUKINSA across indications and throughout the product lifecycle, ensuring alignment with cross-functional objectives.
  • Identify evidence gaps and opportunities, and develop and execute an integrated value evidence generation plan covering disease burden, treatment patterns, comparative effectiveness, indirect comparisons, economic modeling, and patient-centered outcomes to strengthen differentiation and demonstrate clinical and economic value.
  • Design and execute real-world evidence and comparative effectiveness studies using real-world data sources, including claims and electronic health records, to support differentiation.
  • Monitor and assess the evolving clinical, competitive, payer, and evidence landscape for BRUKINSA and relevant hematologic malignancies, assess evidence gaps, and develop HEOR/RWE analyses and evidence-generation strategies to support differentiation and value demonstration.
  • Collaborate with cross-functional partners on payer/JCA/HTA submissions and lead HEOR deliverables, including indirect comparisons and economic modeling.
  • Lead development of Global Value Dossiers and the US AMCP dossier to support reimbursement submissions and value communication.
  • Lead development of health economic models, including cost-effectiveness and budget impact analyses.
  • Drive HEOR/RWE publication strategy and scientific dissemination of HEOR/RWE evidence through abstracts, manuscripts, congress presentations, and omnichannel distributions.
  • Partner with Clinical Development, Biostatistics, Medical Affairs, Regulatory, Commercial, and Market Access teams to integrate HEOR insights into overall program strategy.
  • Manage external vendors and research partners, overseeing study design, project execution, deliverables, timelines, and budgets.
  • Provide strategic HEOR guidance to affiliates and regional teams to support local evidence needs.
  • Provide matrix leadership and oversight of external vendors and consultants, as applicable.

Desired Qualifications

  • Hematology/Oncology experience is strongly preferred.

About the Company

BeOne

Global oncology therapeutics discovery, development, manufacturing

BeOne Medicines discovers, develops, and commercializes oncology therapies worldwide, focusing on hematologic cancers and solid tumors. Its products work by leveraging internal R&D and clinical development to bring therapies to market quickly, with Brukinsa serving as a leading backbone in the US and European markets. It differentiates itself through a large-scale global clinical network and cost-efficient development and manufacturing that support high margins and a focus on large-market cancer indications. Its goal is to expand access to high-impact, affordable cancer treatments across more than 45 countries while growing its pipeline into immunology and solid tumors.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Dongcheng District, China
Founded
2010

Recently Posted Jobs

Explore more opportunities at BeOne

See more jobs